Impact of the COVID-19 pandemic on young people with and without pre-existing mental health problems.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • Subject Terms:
      Pandemics* ; COVID-19*/epidemiology; Adolescent ; Young Adult ; Female ; Humans ; Cross-Sectional Studies ; Mental Health ; Retrospective Studies ; Anxiety/epidemiology ; Menstruation Disturbances ; Depression/epidemiology
    • Abstract:
      The objective was to examine pandemic-related changes in depression and anxiety symptoms in adolescents and young adults in Germany considering pre-existing depression and anxiety problems. In this cross-sectional study, 11,523 adolescents and young adults aged 14-21 years who perceived an impact of the Coronavirus disease (COVID-19) pandemic on their mental health reported the frequencies of depression and anxiety symptoms retrospectively for different pre-pandemic and pandemic phases. Data were collected using web-based questionnaires between January 5th and February 20th, 2022. Depression and anxiety were assessed with a modified version of the Patient Health Questionnaire (PHQ-4). Scale-fit cut-offs were used to identify pre-existing elevated depression and anxiety scores. Multilevel mixed linear models were conducted to assess changes in depression and anxiety symptoms from 2019 to 2021 and compare for age, gender and pre-pandemic mental health problems. Among young people who were experiencing mental health changes as a result of the pandemic, the frequency of depression and anxiety symptoms increased during the COVID-19 pandemic. This association was moderated by age, gender, and pre-existing elevated depression/anxiety scores. For young people without elevated pre-pandemic depression/anxiety, the scores increased strongly over time, with 61% reporting elevated depression symptoms and 44% reporting elevated anxiety symptoms in 2021. In contrast, self-perceived change was minimal for adolescents and young adults with elevated pre-pandemic depression and anxiety. Among young people whose mental health has been affected by the COVID-19 pandemic, the group without pre-pandemic mental health conditions reported greater deterioration than those with elevated pre-pandemic depression and anxiety scores. Thus, adolescents and young adults without pre-existing depression and anxiety problems who perceived a change in general mental health due to the pandemic reported an alarming increase in symptoms of depression and anxiety during the COVID-19 pandemic period.
      (© 2023. The Author(s).)
    • References:
      Cureus. 2022 Mar 8;14(3):e22965. (PMID: 35411264)
      Lancet Psychiatry. 2017 Feb;4(2):146-158. (PMID: 27856392)
      Pediatrics. 2001 Aug;108(2):E31. (PMID: 11483841)
      Int J Psychol. 2022 Feb;57(1):33-42. (PMID: 33938580)
      Int J Psychol. 2021 Aug;56(4):585-593. (PMID: 33942893)
      Front Psychol. 2020 Oct 02;11:567484. (PMID: 33132973)
      Ann Intern Med. 2007 Mar 6;146(5):317-25. (PMID: 17339617)
      JAMA Netw Open. 2022 Apr 1;5(4):e227629. (PMID: 35452109)
      J Psychiatr Res. 2011 Aug;45(8):1027-35. (PMID: 21439576)
      Psychiatry Res. 2020 Nov;293:113462. (PMID: 32987222)
      BMC Psychiatry. 2021 Sep 6;21(1):435. (PMID: 34488697)
      JAMA Pediatr. 2021 Nov 1;175(11):1142-1150. (PMID: 34369987)
      J Affect Disord. 2020 Dec 1;277:55-64. (PMID: 32799105)
      Int J Environ Res Public Health. 2020 Nov 16;17(22):. (PMID: 33207689)
      J Adolesc Health. 2021 Aug;69(2):227-233. (PMID: 34112599)
      Int J Environ Res Public Health. 2022 Jul 30;19(15):. (PMID: 35954706)
      Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Dec;64(12):1512-1521. (PMID: 33649901)
      J Affect Disord. 2022 Sep 1;312:310-314. (PMID: 35760191)
      Front Psychol. 2022 Sep 29;13:964313. (PMID: 36248520)
      J Adolesc Health. 2021 Jul;69(1):26-32. (PMID: 34172140)
      J Public Health (Oxf). 2022 Mar 7;44(1):e88-e95. (PMID: 34179996)
      J Public Health (Oxf). 2020 Nov 23;42(4):672-678. (PMID: 32657323)
      Psychiatry Res. 2019 Sep;279:40-46. (PMID: 31295646)
      J Adolesc Health. 2021 Aug;69(2):211-218. (PMID: 34092475)
      Psychosomatics. 2009 Nov-Dec;50(6):613-21. (PMID: 19996233)
      BMC Musculoskelet Disord. 2020 Jun 30;21(1):415. (PMID: 32605559)
      J Psychiatry Neurosci. 2015 Jul;40(4):219-21. (PMID: 26107348)
      Brain Behav. 2020 Sep;10(9):e01745. (PMID: 32633464)
      J Psychosom Res. 2005 Feb;58(2):163-71. (PMID: 15820844)
      Psychol Bull. 2013 Nov;139(6):1221-59. (PMID: 23627633)
      Cureus. 2022 Jan 10;14(1):e21070. (PMID: 35155028)
      J Psychoactive Drugs. 2021 Jan-Mar;53(1):1-9. (PMID: 33111650)
      Sci Rep. 2022 Jul 15;12(1):12118. (PMID: 35840641)
      J Adolesc Health. 2022 Nov;71(5):570-578. (PMID: 35989235)
      Lancet Psychiatry. 2021 Feb;8(2):121-129. (PMID: 33306975)
      J Adolesc Health. 2022 Oct;71(4):406-413. (PMID: 35725540)
      Lancet Psychiatry. 2021 Aug;8(8):663-672. (PMID: 34090582)
      Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Jul;58(7):749-57. (PMID: 25986532)
      Eval Health Prof. 2021 Jun;44(2):186-191. (PMID: 33926253)
      Pediatr Clin North Am. 2021 Oct;68(5):945-959. (PMID: 34538305)
    • Publication Date:
      Date Created: 20230414 Date Completed: 20230418 Latest Revision: 20230426
    • Publication Date:
      20240628
    • Accession Number:
      PMC10103038
    • Accession Number:
      10.1038/s41598-023-32918-5
    • Accession Number:
      37059814